AstraZeneca is a publicly traded company trading on NASDAQ, led by CEO Pascal Claude Roland Soriot.
Upcoming earnings announcement for AstraZeneca
Past 12 earnings reports for AstraZeneca
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $2.12Est: $2.18 | -2.8% | $15.5BEst: $15.6B | -0.5% | — |
| Nov 6, 2025 | Q3 2025 | $1.19Est: $1.14 | +4.4% | $15.2BEst: $14.8B | +2.6% | — |
| Jul 29, 2025 | Q2 2025 | $1.09Est: $1.10 | -1.4% | $14.5BEst: $14.1B | +2.8% | — |
| Apr 29, 2025 | Q1 2025 | $1.25Est: $1.11 | +12.2% | $13.6BEst: $13.7B | -0.9% | — |
| Feb 6, 2025 | Q4 2024 | $1.05Est: $1.07 | -2.3% | $14.9BEst: $14.2B | +4.8% | — |
| Nov 12, 2024 | Q3 2024 | $1.04Est: $1.03 | +1.0% | $13.6BEst: $13.1B | +3.6% | — |
| Jul 25, 2024 | Q2 2024 | $0.99Est: $1.20 | -17.5% | $13.0BEst: $12.8B | +1.8% | — |
| Apr 25, 2024 | Q1 2024 | $1.03Est: $1.22 | -15.6% | $12.7BEst: $11.8B | +7.2% | — |
| Feb 8, 2024 | Q4 2023 | $0.73Est: $0.79 | -8.2% | $12.0BEst: $12.1B | -0.5% | — |
| Nov 9, 2023 | Q3 2023 | $0.87Est: $0.84 | +3.0% | $11.5BEst: $11.7B | -1.4% | — |
| Jul 28, 2023 | Q2 2023 | $1.08Est: $0.95 | +13.2% | $11.4BEst: $11.0B | +4.2% | — |
| Apr 27, 2023 | Q1 2023 | $0.96Est: $1.07 | -10.3% | $10.9BEst: $10.8B | +1.2% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.